NKGen Biotech Inc NKGN shares traded higher on Monday, with a strong session volume of 19.25 million, compared to an average…
Friday, Hepion Pharmaceuticals Inc. HEPA said it has begun winding down activities in its ASCEND-NASH Trial while continuing to explore strategic alternatives,…
On Monday, Eli Lilly and Company LLY agreed to acquire a manufacturing facility from Nexus Pharmaceuticals. The deal terms were not disclosed. The acquisition of this…
Phio Pharmaceuticals Corp PHIO shares are trading higher after the company announced it is presenting new data about its lead clinical…
The U.S. Supreme Court has reportedly chosen not to review Vanda Pharmaceuticals Inc’s VNDA attempt to revive patents for its sleep-disorder medication Hetlioz,…
Monday, Corcept Therapeutics Incorporated CORT released results from the open-label portion of the pivotal Phase 3 GRACE trial of its proprietary selective…
Plus Therapeutics Inc PSTV has been selected for $3 million in funding recommendation by the Department of Defense (DoD) office of…
A recent survey conducted by Morgan Stanley reveals that the use of GLP-1 drugs, popular for weight loss and diabetes, is affecting…
On April 16, 2024, the United States Patent and Trademark Office issued patent number 11957664 to Adial Pharmaceuticals Inc ADIL. This patent…
MALVERN, Pa., April 19, 2024 (GLOBE NEWSWIRE) — Ocugen, Inc. (“Ocugen” or the “Company”) OCGN, a biotechnology company focused on…